Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-000350

CHF CORP DEVEL OFF, GEN COUNS acquired 167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS 2023-12-29 Grant or award +167 $1.72 $287 11,655 D
Loading xslF345X05/form4-01032024_100124.xml…